Graphene Composites have been selected as one of the companies that will participate in the Microbials Accelerator Programme, funded by Innovate UK and co-led by Bionow and LYVA Labs.
Funded by Innovate UK as part of the Biomedical Catalyst the Accelerator is co-led by LYVA Labs and Bionow, in collaboration with CPI, iiCON, The Innovation Agency and the University of Liverpool, the programme consists of a unique package of business support and access to clinical/technical advice at no cost to the company.
The scope of which is the technology that has the potential to impact microbial communities or biofilms related to health. The programme will include a ‘pre-accelerator’ for a handful of entrepreneurs.
